-+ 0.00%
-+ 0.00%
-+ 0.00%

Colgate Palmolive (CL) Stock Looks Cheap Against Its Cash Flow

Simply Wall St·10/20/2026 18:26:41
語音播報

Colgate-Palmolive has delivered a steady climb in recent years, which naturally raises a question for anyone looking at the stock today. Has the share price run ahead of, kept pace with, or lagged behind the cash flows that actually support the business?

  • Over the past 5 years the stock has returned about 40.0%, which puts real weight on whether the underlying cash generation matches that kind of compounding.
  • The company’s long established brands and focus on everyday consumer products can support relatively consistent cash flows, which makes a valuation based on its cash generation particularly important.
  • If you'd rather focus on earnings, this one's for you. See why Colgate-Palmolive's 36.5x P/E tells a different valuation story.

For investors, the debate is whether Colgate-Palmolive’s current US$93.39 share price is adequately supported by the cash flows implied in its intrinsic value estimate from the Discounted Cash Flow (DCF) approach.

To test whether Colgate-Palmolive’s current cash flow support is unique or part of a broader pattern, compare it with a wider pool of companies using the 35 high quality undervalued stocks

Is Colgate-Palmolive a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) model here looks at the cash Colgate-Palmolive is expected to generate for shareholders and then adjusts those streams back to today’s dollars. On the latest twelve month view, the business produced roughly $3.9b of free cash flow, which sets a sizeable base before any future growth assumptions are layered on.

Analysts feeding into this 2 Stage Free Cash Flow to Equity framework are not baking in explosive expansion. They are pencilling in gradually rising free cash flows over the coming decade, which fits a mature, brand driven consumer products group like Colgate-Palmolive. When those projected cash streams are discounted and added together, the model points to an intrinsic value that sits meaningfully above the current US$93.39 share price. This implies the market price is not fully reflecting the cash generation profile yet. Find out what Colgate-Palmolive could be worth using our Discounted Cash Flow (DCF) estimate.

The Colgate-Palmolive Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the DCF puzzle leaves off. They spell out what mix of future growth, margins and earnings power would need to hold for Colgate-Palmolive to be worth materially more or less than today’s share price, and they sit on the stock’s Community page. Each narrative ties its valuation angle to a clear view on how Colgate-Palmolive's growth profile, profitability and key risks might evolve, which gives you something concrete to revisit as fresh information comes through.

Community views on Colgate-Palmolive split between a premium and emerging markets upside story and a cleaner, more conservative read of the current valuation.

Bull case: 5% undervalued

"Expansion and premiumization of core oral care lines like Colgate Total, now supported by a broader push into premium Oral, Home and Personal Care offerings such as Optic White Pro Series, Fabuloso sprays and premium Palmolive dish pumps, aims to lift pricing power and mix, which can support revenue growth and gross margin..."

Discover why this Narrative puts Colgate-Palmolive at 5% undervalued.

Bear case: 8% overvalued

"This creates a trap worth naming. If you normalise the margin but leave the future multiple at the GAAP-derived figure, you count the adjustment twice and overstate fair value by roughly 45%..."

Explore why this Narrative puts Colgate-Palmolive at 8% overvalued.

One more question for Colgate-Palmolive that the valuation does not answer

Price and cash flows only tell part of the story, because Simply Wall St’s broader checks have also raised specific concerns about Colgate-Palmolive that careful investors may want to examine before forming a view. Take a closer look at 3 warning signs before settling on a valuation.